{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:09:36Z","timestamp":1787843376254,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2022HWYQ-080"],"award-info":[{"award-number":["2022HWYQ-080"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022QC163"],"award-info":[{"award-number":["ZR2022QC163"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177527","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:52:29Z","timestamp":1742370749000},"page":"177527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Alectinib causes sinus bradycardia by suppressing L-type calcium current in sinus node"],"prefix":"10.1016","volume":"998","author":[{"given":"Guo-Xuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Chen","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Zhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3270-7651","authenticated-orcid":false,"given":"Dong-Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177527_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nn.2694","article-title":"Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness","volume":"14","author":"Baig","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177527_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtho.2019.03.007","article-title":"Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non\u2013small cell lung cancer in the global-phase III ALEX study","volume":"14","author":"Camidge","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejphar.2025.177527_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/CLEP.S69718","article-title":"Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors","volume":"6","author":"Chia","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ejphar.2025.177527_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCRESAHA.109.208041","article-title":"The role of the funny current in pacemaker activity","volume":"106","author":"DiFrancesco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177527_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40265-018-0916-4","article-title":"Targeting EGFR in lung cancer: current standards and developments","author":"D\u00edaz-Serrano","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.177527_bib6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/CIRCRESAHA.123.323250","article-title":"Pacemaker channels and the chronotropic response in health and disease","volume":"134","author":"Hennis","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177527_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jacc.2019.06.066","article-title":"Right atrial mechanisms of atrial fibrillation in a rat model of right heart disease","volume":"74","author":"Hiram","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177527_bib8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jacc.2014.05.077","article-title":"Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model","volume":"64","author":"Iwasaki","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177527_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fphar.2020.00891","article-title":"A comprehensive review of clinical cardiotoxicity incidence of FDA-approved small-molecule kinase inhibitors","volume":"11","author":"Jin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177527_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nbt.2465","article-title":"Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18","volume":"31","author":"Kapoor","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.177527_bib12","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/s41467-021-22737-5","article-title":"Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177527_bib13","article-title":"Anaplastic lymphoma kinase tyrosine kinase inhibitor-associated cardiotoxicity: a recent five-year pharmacovigilance study","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177527_bib14","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1073\/pnas.0935295100","article-title":"Functional role of L-type CaV1.3 Ca2+ channels in cardiac pacemaker activity","volume":"100","author":"Mangoni","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2025.177527_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.RES.0000225862.14314.49","article-title":"Bradycardia and slowing of the atrioventricular conduction in Mice lacking CaV3.1\/\u03b11G T-Type calcium channel","volume":"98","author":"Mangoni","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177527_bib16","doi-asserted-by":"crossref","first-page":"H2710","DOI":"10.1152\/ajpheart.01399.2006","article-title":"Aldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytes","volume":"293","author":"Muto","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2025.177527_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-017-3253-5","article-title":"Effect of alectinib on cardiac electrophysiology: results from intensive electrocardiogram monitoring from the pivotal phase II NP28761 and NP28673 studies","volume":"79","author":"Morcos","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177527_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejphar.2025.177527_bib19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-018-0952-0","article-title":"Alectinib: a review in advanced, ALK-positive NSCLC","volume":"78","author":"Paik","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.177527_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","article-title":"Genetic alterations defining NSCLC subtypes and their therapeutic implications","volume":"82","author":"Pikor","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejphar.2025.177527_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11864-020-00764-6","article-title":"Cardiovascular toxicities of Bruton's tyrosine kinase inhibitors","volume":"21","author":"Pineda-Gayoso","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejphar.2025.177527_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0092-8674(00)00013-1","article-title":"Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-Type Ca2+ channels","volume":"102","author":"Platzer","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177527_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaccao.2022.09.006","article-title":"Cardiac toxicity of alectinib in patients with ALK+ lung cancer: outcomes of Cardio-Oncology Follow-Up","volume":"5","author":"Pruis","year":"2022","journal-title":"JACC. CardioOncol."},{"key":"10.1016\/j.ejphar.2025.177527_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ccr.2011.04.004","article-title":"CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant","volume":"19","author":"Sakamoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2025.177527_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2019.07.056","article-title":"Cardiovascular toxicities associated with ibrutinib","volume":"74","author":"Salem","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177527_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S1470-2045(13)70142-6","article-title":"CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study","volume":"14","author":"Seto","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2025.177527_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40264-013-0047-5","article-title":"Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)","volume":"36","author":"Shah","year":"2013","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2025.177527_bib28","first-page":"1","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177527_bib36","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1038\/s41598-017-08191-8","article-title":"CaV1.3 L-type Ca2+channel contributes to the heartbeat by generating a dihydropyridine-sensitive persistent Na+ current","volume":"7","author":"Toyoda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177527_bib29","article-title":"Genetics of sinoatrial node function and heart rate disorders","volume":"16","author":"Van","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejphar.2025.177527_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal src kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177527_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/CIRCULATIONAHA.108.789677","article-title":"Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: molecular basis for tachycardia-bradycardia syndrome","volume":"119","author":"Yeh","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177527_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1759-7714.14769","article-title":"High incidence and reversible bradycardia events following alectinib initiation","volume":"14","author":"Yuan","year":"2023","journal-title":"Thorac. Cancer."},{"key":"10.1016\/j.ejphar.2025.177527_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030353","article-title":"Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis","volume":"7","author":"Zang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177527_bib34","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.105.540070","article-title":"Functional roles of CaV1.3 (\u03b11D) calcium channels in atria: insights gained from gene-targeted null mutant mice","volume":"112","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177527_bib35","first-page":"1","article-title":"Crizotinib inhibits hyperpolarization-activated cyclic nucleotide-gated channel 4 activity","volume":"3","author":"Zhang","year":"2017","journal-title":"Cardiooncology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T12:48:25Z","timestamp":1746967705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992500281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"alternative-id":["S001429992500281X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177527","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alectinib causes sinus bradycardia by suppressing L-type calcium current in sinus node","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177527"}}